A. Prevents synthesis of prothrombin
B. Prevents synthesis of fibrinogen
C. Prevents conversion of fibrinogen to fibrin
D. Prevents prothrombin conversion to thrombin
A. Warfarin
B. Insultin
C. Glibeneclamide
D. Gluengon
A. It is taken orally
B. It is used in type-I diabetes mellitus
C. It causes alcohol intolerance
D. It acts on pancreas to stimulate release of insulin
A. Miosis
B. Yawning
C. Lacrimation
D. Diarrhoea
A. Transient hypercoagulability is seen
B. Better avoided during pregnancy as it may causes skeletal deformity of the foetus
C. In a racemic mixture the R form is four times more active than the S form
D. The anticoagulant effect is seen only after 72 hours of administration
A. Phenylbutazone
B. Vitamin K
C. Rifampicin
D. B & C
A. Anti-inflaqmmatory drug
B. Antibiotic
C. Anti-arthritic drug
D. Antiplatelet drug
A. Astrigents
B. Styptics
C. Haemostatics
D. All of the above
A. Anticholinesterases
B. Alpha-adrenergic blocking agents
C. Indirect acting sympathomimetics
D. Direct acting sympathomimetics